Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C11orf88 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SF3B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRCC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RMDN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929953 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KRT35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABGAP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GK5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC27A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on